Navigation Links

Biology Technology

Zansors Announces Issued Patent Protecting Adhesive for Wearable Health Sensors

Arlington, VA (PRWEB) March 29, 2017 Zansors announced today its first utility patent for a wearable patch comprising multiple separable adhesive layers, as issued by the U.S. Patent & Trademark Office (USPTO). The patent covers a wearable patch with stackable adhesive layers as it applie... [Comments]

Crohn’s & Colitis Foundation and ReachMD Partner to Deliver Educational Information to Healthcare Professionals

Fort Washington, PA (PRWEB) March 29, 2017 The Crohn’s & Colitis Foundation , the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD), and ReachMD , the nation’s largest medical education learning platform for healthcare pr... [Comments]

CSL Behring Awards Grant To Patient Groups To Develop Innovative Ways To Advocate For Patients

KING OF PRUSSIA, Pa. , March 29, 2017 Patients are the most compelling advocates for access to care, which is why CSL Behring awards Local Empowerment for Advocacy Development (LEAD) grants to support advocacy work of rare disease patient groups. These groups tackle complex legislative and public policy issues and ensure patients' voices are heard on Capitol Hill and in stateh... [Comments]

Vermillion Reports Fourth Quarter and Full Year 2016 Results

AUSTIN, Texas, March 29, 2017  Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its results for the fourth quarter and full year ended December 31, 2016. "2016 marked a pivotal year for us with our first clinical utility publication, ACOG guideline inclusion, international distribution agreements, major reimburs... [Comments]

QIAGEN Launches First FDA-cleared JAK2 Test for Certain Type of Leukemia

GERMANTOWN, Maryland , and HILDEN, Germany , March 29, 2017 QIAGEN N.V. (NASDAQ: QGEN ; FRANKFURT PRIME STANDARD: QIA) today announced the U.S. launch of its ipsogen ® JAK2 RGQ PCR Kit ( ipsogen JAK2 assay), which was cleared by the U.S. Food and Drug Administration as a qualitative in vitro diagnostic test for the detection of the JAK2 V617F/G1849T allele in... [Comments]

Gesture Recognition and Touchless Sensing Market by Technology, Product, Industry, and Geography - Global Forecast to 2022

NEW YORK , March 29, 2017 "Surging application of gesture control features in automobiles and favorable programs deployed by the government are expected to drive the growth of gesture recognition and touchless sensing market" The gesture recognition market is expected to be worth USD 18.98 billion by 2022, growing at a CAGR of 29.63% between 2017 and 2022. The touchless sens... [Comments]

Drugs Derived from Kratom & Cannabis focus on New Organic Market Research Study for Pain Medicine Solutions

COLORADO SPRINGS, CO , March 29, 2017 /PRNewswire/ - Last year's petition to the White House signed by 120,000 people who support kratom are not the only efforts active to generate awareness on the importance of new organic medicines and nutritional products that substitute opiate based pharmaceutical drugs in the healthcare market place. Earlier this month Health... [Comments]

WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC

SHANGHAI , March 29, 2017 WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec Affiliate, today announced that it had received the 2017 Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC, a leading consulting firm. Asia-Pacific Bioprocessing Excellence Awards aims to recognize outstanding... [Comments]

BrainStorm Announces Financial Results for 2016 and Provides Business Update

HACKENSACK, N.J. and PETACH TIKVAH, Israel , March 30, 2017  BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced financial results for the year ended December 31, 2016. "2016 was a highly successful and pivotal year for Brainstorm, with a number of important achievem... [Comments]

Nerium International Approved as Member of the Mexican Direct Selling Association A.C.

Addison, Tx (PRWEB) March 29, 2017 (March 29, 2017) — Nerium International is honored to announce that Nerium International Mexico has been approved as an active member of the Mexican Direct Selling Association A.C. (AMVD ). The AMVD works to achieve satisfaction and protection among distr... [Comments]

ComplianceOnline Announces Medical Device Summit 2017 Venue and Speaker Line Up

Palo Alto, CA, USA (PRWEB) March 29, 2017 ComplianceOnline, the leading governance, risk and compliance advisory network with over 1500 experts in various regulatory subjects has announced its 3rd Annual Medical Device Summit 2017 venue and speaker lineup. The Summit will take place on June 8... [Comments]

Medicine Technology

Intraoperative Neuromonitoring (IONM) Market to Reach $3.6 Billion by 2025 - Growing Popularity of IONM Amongst Surgical Teams, Surgeons & Hospitals - Research and Markets

DUBLIN , Mar. 29, 2017 Research and Markets has announced the addition of the "Intraoperative Neuromonitoring (IONM) Market Size & Forecast By Type (Insource IONM, Outsource IONM), By Region And Trend Analysis From 2014 - 2025" report to their offering. The global Intraoperative Neuromonitoring (IONM) market is expected to reach USD 3.6 billion by 2... [Comments]

Bodycad Receives FDA 510K Clearance for Personalized Unicompartmental Knee System

QUEBEC CITY , March 29, 2017  Bodycad announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental Knee System, enabling the commercial launch of this truly personalized orthopaedic restoration. Bodycad is the first Canadian company to receive FDA clearance for a joint reconstruction implant system. Bodyc... [Comments]

Wound Care Devices Market Global Briefing 2017

NEW YORK , March 29, 2017 Wound care devices and products are used to prevent infection and promote healing of the wound. The industry mainly consists of establishments engaged in manufacturing wound care devices and products for the treatment of wounds caused by mechanical, chemical, thermal, and radiogenic trauma; and wounds that occur due to diseases such as diabetes, skin... [Comments]

Research and Markets - Global Energy-based Aesthetic Devices Market to Grow at a CAGR of 8.12% by 2017-2021, with Cutera, Cynosure, Lumenis & Syneron Medical Dominating

DUBLIN , Mar. 29, 2017 Research and Markets has announced the addition of the "Global Energy-Based Aesthetic Devices Market 2017-2021" report to their offering. The global energy-based aesthetic devices market to grow at a CAGR of 8.12% during the period 2017-2021. The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has been prepared... [Comments]

Research and Markets - Global Gas Chromatograph Market to Grow at a CAGR of 5.2% by 2017-2021, with Agilent Technologies, PerkinElmer, Shimadzu & Thermo Fisher Scientific Leading the Way

DUBLIN , Mar. 29, 2017 Research and Markets has announced the addition of the "Global Gas Chromatograph Market 2017-2021" report to their offering. The global gas chromatograph market to grow at a CAGR of 5.20% during the period 2017-2021. The report, Global Gas Chromatograph Market 2017-2021, has been prepared based on an in-depth market analysis wi... [Comments]

Global Intravenous (IV) Iron and Oral Iron Market - Strategic Assessment and Forecast Till 2021

NEW YORK , March 29, 2017 Global intravenous (IV) iron and oral iron market is expected to cross US$ 3 billion by 2021, growing at a CAGR of 5%. Iron drugs are the supplements containing iron prescribed by a doctor to treat anemia or other iron deficiencies. Oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administra... [Comments]

Avelas Biosciences to Present at Needham & Company 16th Annual Healthcare Conference

SAN DIEGO , March 29, 2017 Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced that Carmine N. Stengone , president and chief executive officer, will present an overview of the company at the Needham & Company 16 th Annual Healthcare Conference on Wednesday, April... [Comments]

BioSpecifics Technologies Corp. to Present at the 16th Annual Needham Healthcare Conference

LYNBROOK, N.Y. , March 29, 2017  BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum (CCH) marketed as XIAFLEX ®  in the U.S. and Xiapex ®  in Europe, today announced that management... [Comments]

Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted FDA Priority Review

EAST HANOVER, N.J. , March 29, 2017  Novartis announced today that the US Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) filing and granted priority review for CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell (CAR-T) therapy, in relapsed and refractory (r/r) pediatric and young adult patient... [Comments]

Italy Proton Therapy Market Forecast to 2021 - Therapy Centers are Significantly Increasing their Capacity to Treat Patients - Research and Markets

DUBLIN , Mar. 29, 2017 Research and Markets has announced the addition of the "Italy Proton Therapy Market, Patients Treated at Proton Therapy Centers & Forecast" report to their offering. Proton Therapy Market in Italy will double by the end of 2021 from its market value in 2016. There are currently three proton therapy centers in Italy tha... [Comments]

Reynolds, State Officials and CVS Health Announce Availability of Naloxone at All CVS Pharmacy Locations in Iowa

DES MOINES, Iowa , March 29, 2017 Today, CVS Health officials (NYSE: CVS ) joined Iowa Lt. Gov. Kim Reynolds , Department of Public Health Director Gerd Clabaugh and Office of Drug Control Policy Director Steve Lukan in announcing the availability of the opioid overdose-reversal medicine naloxone without a prescription at all CVS Pharmacy locations in Iowa.  CVS He... [Comments]

(Date:3/29/2017)... -- Research and Markets has announced the addition of ... Forecast to 2025" report to their offering. ... The Global Agricultural Chelates Market ... the next decade to reach approximately $825.4 million by 2025. ... for all the given segments on global as well as regional ...
(Date:3/29/2017)... 29, 2017 /PRNewswire/ - The University of Missouri Research ... business of Sterigenics International, and General Atomics (GA), announce ... to the U.S. Nuclear Regulatory Commission (NRC). This marks ... molybdenum-99 (Mo-99). Once operational, production from this facility will ... for Mo-99, which currently must be imported from outside ...
(Date:3/29/2017)... Research and Markets has announced the ... Markets" report to their offering. ... The study scope includes ... RNA interference, synthetic biology tools and genome editing tools); synthetic ... These technologies and products are analyzed to determine present and ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the Advancement of Science (AAAS), the world's largest general scientific society and ... high-impact scholarly collection across its cross-platform reference management system. , All six ...
Breaking Biology Technology:
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets has ... Policy, Patients Treated at Proton Therapy Centers & Forecast" report to ... The South ... its current market size in 2016. The Untapped Proton Therapy Market for ... Billion USD in 2016. Proton Therapy plays an important ...
(Date:3/29/2017)... , Mar 29, 2017  Providence Medical ... announced the addition of two industry veterans to ... has joined the company to lead Global Marketing, ... leadership.  Together, Mr. Lynch and Mr. Scott have ... Mr. Lynch joins the company with ...
(Date:3/29/2017)...  Zynex (OTCQB: ZYXI), an innovative medical technology company specializing ... for pain management, stroke rehabilitation, cardiac monitoring and neurological ... 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 a.m. ... expects to file its 2016 full year financial results ... ...
Breaking Medicine Technology: